Glenmark’s outlicensing deal with AbbVie for a novel drug for blood cancer under development sets a new course for the ...

Fast Retailing has a solid balance sheet with a JPY 163 billion net cash position, including lease liabilities as of Feb. 28, 2025. Management considers it necessary to hold plenty of cash on hand, ...